Immunome
(NASDAQ:IMNM)
$5.36
0.19[3.68%]
At close: Aug 12
$4.65
-0.71[-13.25%]
After Hours: 4:42PM EDT
Day High/Low5.11 - 5.69
52 Week High/Low2.09 - 14.11
Open / Close5.25 / 5.36
Float / Outstanding10.6M / 12.1M
Vol / Avg.57.3K / 41.5K
Mkt Cap65M
P/E-
50d Avg. Price3.75
Div / Yield-
Payout Ratio-
EPS-0.74
Total Float10.6M

Immunome (NASDAQ:IMNM), Earnings Estimates, EPS, and Revenue

Immunome reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 5

EPS

$-0.740

Quarterly Revenue

$0K

Annual Revenue (as of Jun 30)

Earnings Recap

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 11.81% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Immunome using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

Immunome Questions & Answers

Q
When is Immunome (NASDAQ:IMNM) reporting earnings?
A

Immunome (IMNM) is scheduled to report earnings on November 14, 2022. The last reported earnings were for reported on August 5, 2022 for Q2.

Q
What were the latest earnings per share (EPS) for Immunome (NASDAQ:IMNM)?
A

The Actual EPS was $-7.52, which missed the estimate of $0.00.

Q
What were Immunome’s (NASDAQ:IMNM) revenues?
A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.